Stock Report

Solara Active Pharma Sciences Ltd consolidated Q2 FY2024 loss at Rs. 17.16 crores

Posted On : 2023-11-15 10:59:14( TIMEZONE : IST )

Solara Active Pharma Sciences Limited has reported Consolidated financial results for the period ended September 30, 2023.

Financial Results (Q2 FY2024) - QoQ Comparison

The company has reported total income of Rs. 426.42 crores during the period ended September 30, 2023 as compared to Rs. 354.35 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs. -17.16 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. -19.55 crores for the period ended June 30, 2023.

The company has reported EPS of Rs. -4.77 for the period ended September 30, 2023 as compared to Rs. -5.43 for the period ended June 30, 2023.

Financials	Q2 FY2024	Q1 FY2024	% Change
Total Income	₹ 426.42 crs	₹354.35 crs	20.34%
Net Profit	₹-17.16 crs	₹-19.55 crs	12.23%
EPS	₹-4.77	₹-5.43	12.15%

Financial Results (Q2 FY2024) - YoY Comparison

The company has reported total income of Rs. 426.42 crores during the period ended September 30, 2023 as compared to Rs.342.09 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs.-17.16 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.-9.96 crores for the period ended September 30, 2022.

The company has reported EPS of Rs.-4.77 for the period ended September 30, 2023 as compared to Rs.-2.77 for the period ended September 30, 2022.

Financials	Q2 FY2024	Q2 FY2023	% Change
Total Income	₹ 426.42 crs	₹342.09 crs	24.65%
Net Profit	₹-17.16 crs	₹-9.96 crs	72.29%
EPS	₹-4.77	₹-2.77	72.20%

Financial Results (Half Year Ended FY2024) - YoY Comparison

The company has reported total income of Rs.780.77 crores during the 6 Months period ended September 30, 2023 as compared to Rs.679.14 crores during the 6 Months period ended September 30, 2022.

The company has posted net profit / (loss) of Rs.-36.71 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.-26.39 crores for the 6 Months period ended September 30, 2022.

The company has reported EPS of Rs.-10.20 for the 6 Months period ended September 30, 2023 as compared to Rs.-7.33 for the 6 Months period ended September 30, 2022.

Financials	Half Year Ended FY2024	Half Year Ended FY2023	% Change
Total Income	₹780.77 crs	₹679.14 crs	14.96%
Net Profit	₹-36.71 crs	₹-26.39 crs	39.11%
EPS	₹-10.20	₹-7.33	39.15%

Shares of Solara Active Pharma Sciences Limited was last trading in BSE at Rs. 347.25 as compared to the previous close of Rs. 331.10. The total number of shares traded during the day was 16755 in over 1323 trades.

The stock hit an intraday high of Rs. 348.00 and intraday low of 331.75. The net turnover during the day was Rs. 5746251.00.